In addition, in the current study, we show that CD40 rs1883832 is associated with total CD40 expression in tumorous cells as well as in stromal cells, suggesting a possible mechanism through which CD40 rs1883832 may influence survival outcome of NSCLC patients. Here, CD40 is linked to non-small cell lung carcinoma.